Apollo Therapeutics
Listed company · Equity Storytelling, Investor Platforms
Apollo Therapeutics is a clinical-stage biopharmaceutical company focused on developing first-in-class therapies. Following their IPO on Nasdaq in 2024, they needed investor communications that would present the science, the pipeline, and the commercial strategy clearly to public market investors.
“Investor communications that present the science, the pipeline, and the commercial strategy clearly to public market investors”
We developed a comprehensive investor communications package: brand identity, equity story, and a digital investor platform. The brand was designed to carry scientific credibility while meeting the expectations of institutional investors conducting due diligence on a newly listed company.
Brand snapshot
Brand guidelines
Implementing the brand
Website
